DORAVIRINE

DORAVIRINE was reported 788 times

DORAVIRINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD HIV RNA FLUCTUATION 1 0.1111
1 INCOMPLETE COURSE OF VACCINATION 1 0.1000
2 FLOPPY EYELID SYNDROME 3 0.0857
3 LISTERAEMIA 2 0.0800
4 PLETHORIC FACE 2 0.0690
5 VIRAL LOAD ABNORMAL 10 0.0571
6 PRIMARY SYPHILIS 1 0.0526
7 LUPUS HEPATITIS 1 0.0417
8 LONG QT SYNDROME CONGENITAL 3 0.0333
9 PSYCHOTHERAPY 1 0.0333
10 CSF HIV ESCAPE SYNDROME 4 0.0290
11 DRUG RESISTANCE MUTATION 5 0.0281
12 CD4 LYMPHOCYTE PERCENTAGE DECREASED 1 0.0227
13 PROSTATIC DYSPLASIA 1 0.0222
14 JEJUNECTOMY 1 0.0222
15 MESENTERIC PANNICULITIS 6 0.0201
16 INFUSION SITE DRYNESS 1 0.0185
17 HYPERPHOSPHATURIA 2 0.0171
18 HEPATIC ARTERY THROMBOSIS 5 0.0171
19 HYPOZINCAEMIA 1 0.0169
20 PASTEURELLA INFECTION 2 0.0155
21 BLOOD HIV RNA INCREASED 28 0.0154
22 AIDS RELATED COMPLICATION 1 0.0154
23 HIV VIRAEMIA 3 0.0143
24 DISSEMINATED COCCIDIOIDOMYCOSIS 2 0.0142
25 INTERVENTIONAL PROCEDURE 1 0.0135
26 COLD TYPE HAEMOLYTIC ANAEMIA 3 0.0128
27 LATENT AUTOIMMUNE DIABETES IN ADULTS 2 0.0117
28 HYPERAROUSAL 1 0.0116
29 MAXILLOFACIAL OPERATION 1 0.0115
30 COELIAC ARTERY STENOSIS 1 0.0110
31 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 3 0.0108
32 PENILE INFECTION 2 0.0103
33 ANORECTAL POLYP 1 0.0093
34 HIV-ASSOCIATED NEUROCOGNITIVE DISORDER 1 0.0090
35 MUCOSAL INFECTION 2 0.0085
36 CD4 LYMPHOCYTES DECREASED 18 0.0084
37 NECROTIC LYMPHADENOPATHY 1 0.0083
38 CONGENITAL SKIN DIMPLES 2 0.0083
39 MESENTERIC ARTERY STENOSIS 1 0.0082
40 AMYLASE ABNORMAL 1 0.0080
41 GENOTYPE DRUG RESISTANCE TEST POSITIVE 8 0.0078
42 BONE DEMINERALISATION 8 0.0076
43 HYPERPLASTIC CHOLECYSTOPATHY 1 0.0074
44 PANCREATIC DUCT DILATATION 2 0.0073
45 DUCTAL ADENOCARCINOMA OF PANCREAS 2 0.0072
46 BETA 2 MICROGLOBULIN URINE INCREASED 1 0.0070
47 VIRAL MUTATION IDENTIFIED 25 0.0068
48 PANCREATIC INJURY 2 0.0066
49 VIROLOGIC FAILURE 34 0.0063
50 MYCOBACTERIUM KANSASII INFECTION 1 0.0061
51 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
52 VISCERAL LEISHMANIASIS 4 0.0055
53 CD4 LYMPHOCYTES ABNORMAL 1 0.0048
54 LIPODYSTROPHY ACQUIRED 10 0.0047
55 PATHOGEN RESISTANCE 42 0.0046
56 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 4 0.0046
57 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0045
58 LIPASE ABNORMAL 1 0.0045
59 HYPERINSULINAEMIC HYPOGLYCAEMIA 1 0.0045
60 HIGH DENSITY LIPOPROTEIN ABNORMAL 1 0.0043
61 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 20 0.0040
62 FACIAL WASTING 1 0.0037
63 BURSITIS INFECTIVE 2 0.0037
64 DEVICE MAINTENANCE ISSUE 2 0.0034
65 EXTRAPULMONARY TUBERCULOSIS 1 0.0034
66 ANOGENITAL WARTS 3 0.0034
67 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 1 0.0032
68 LIPOHYPERTROPHY 2 0.0032
69 WOUND INFECTION PSEUDOMONAS 1 0.0032
70 GLOMERULOSCLEROSIS 2 0.0032
71 SERUM FERRITIN ABNORMAL 1 0.0031
72 ALLERGY TO ARTHROPOD BITE 1 0.0031
73 EXTRAOCULAR MUSCLE DISORDER 1 0.0031
74 BASAL GANGLIA INFARCTION 1 0.0029
75 NEONATAL INFECTION 1 0.0029
76 RECTAL CANCER METASTATIC 1 0.0029
77 ANDROGEN DEFICIENCY 1 0.0028
78 SYPHILIS 2 0.0028
79 EOSINOPHILIC COLITIS 1 0.0027
80 PERFORATED ULCER 2 0.0026
81 DISEASE RISK FACTOR 1 0.0025
82 GLOMERULONEPHRITIS 6 0.0024
83 VIRAL LOAD INCREASED 9 0.0023
84 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 3 0.0023
85 CONGESTIVE HEPATOPATHY 1 0.0022
86 OESOPHAGEAL ADENOCARCINOMA 1 0.0021
87 ANAL CANCER 2 0.0021
88 TOBACCO USER 3 0.0020
89 ULNA FRACTURE 2 0.0020
90 ANHEDONIA 53 0.0020
91 GASTROINTESTINAL TUBE INSERTION 5 0.0020
92 CAROTID ARTERIOSCLEROSIS 2 0.0019
93 ACQUIRED IMMUNODEFICIENCY SYNDROME 1 0.0019
94 INFUSION SITE CELLULITIS 1 0.0019
95 COATING IN MOUTH 1 0.0019
96 ALBUMINURIA 1 0.0019
97 METABOLIC SYNDROME 3 0.0018
98 HELICOBACTER TEST POSITIVE 1 0.0018
99 STRESS AT WORK 2 0.0018
100 PROSTATECTOMY 1 0.0017
101 ALOPECIA AREATA 3 0.0017
102 DRUG RESISTANCE 43 0.0017
103 GAMMA-GLUTAMYLTRANSFERASE ABNORMAL 1 0.0017
104 RENAL TUBULAR INJURY 2 0.0016
105 PROTHROMBIN TIME RATIO DECREASED 1 0.0016
106 HEPATITIS B REACTIVATION 5 0.0016
107 DYSLIPIDAEMIA 8 0.0016
108 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
109 ADJUSTMENT DISORDER 2 0.0015
110 MYELOPROLIFERATIVE NEOPLASM 1 0.0015
111 INSULIN RESISTANCE 3 0.0014
112 RENAL TUBULAR DISORDER 4 0.0014
113 LIPIDS ABNORMAL 1 0.0014
114 LIVER TRANSPLANT 5 0.0014
115 DIET REFUSAL 1 0.0014
116 SKIN STRIAE 2 0.0013
117 SECONDARY ADRENOCORTICAL INSUFFICIENCY 2 0.0013
118 ECONOMIC PROBLEM 20 0.0013
119 DEBRIDEMENT 1 0.0013
120 MULTIPLE-DRUG RESISTANCE 4 0.0013
121 GALLBLADDER POLYP 1 0.0013
122 MITOCHONDRIAL TOXICITY 1 0.0012
123 ALLERGIC SINUSITIS 1 0.0012
124 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
125 LUNG OPACITY 3 0.0011
126 BLOOD ALBUMIN INCREASED 1 0.0011
127 OSTEOPENIA 17 0.0011
128 INJECTION SITE ULCER 1 0.0011
129 INTRACRANIAL MASS 1 0.0011
130 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
131 IDIOSYNCRATIC DRUG REACTION 1 0.0010
132 STRABISMUS 3 0.0010
133 GENE MUTATION 2 0.0010
134 GASTRECTOMY 1 0.0010
135 CACHEXIA 5 0.0010
136 GALLBLADDER ENLARGEMENT 1 0.0009
137 INFUSION SITE MASS 1 0.0009
138 PRODUCT NAME CONFUSION 1 0.0009
139 HENOCH-SCHONLEIN PURPURA 2 0.0009
140 COCCIDIOIDOMYCOSIS 1 0.0008
141 PNEUMOCYSTIS JIROVECII INFECTION 1 0.0008
142 GLYCOSYLATED HAEMOGLOBIN ABNORMAL 1 0.0008
143 FEBRILE CONVULSION 1 0.0008
144 LIPOMA 2 0.0008
145 BONE DENSITY DECREASED 24 0.0008
146 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
147 CENTRAL NERVOUS SYSTEM LYMPHOMA 1 0.0007
148 RENAL ARTERY STENOSIS 1 0.0007
149 BILIARY TRACT DISORDER 1 0.0007
150 VIRAEMIA 1 0.0007
151 HEPATIC CYTOLYSIS 9 0.0007
152 METASTATIC NEOPLASM 3 0.0007
153 HYPERTONIC BLADDER 2 0.0007
154 TREATMENT NONCOMPLIANCE 37 0.0007
155 ODYNOPHAGIA 4 0.0007
156 MENTAL FATIGUE 1 0.0007
157 STEROID DIABETES 1 0.0007
158 SMALL CELL LUNG CANCER 1 0.0007
159 END STAGE RENAL DISEASE 12 0.0007
160 HEPATOCELLULAR CARCINOMA 5 0.0007
161 INFECTIOUS PLEURAL EFFUSION 1 0.0007
162 INJECTION SITE PARAESTHESIA 1 0.0007
163 CALCULUS URINARY 1 0.0006
164 OSTEOMALACIA 1 0.0006
165 MYELITIS 1 0.0006
166 GASTROSTOMY 1 0.0006
167 FAMILY STRESS 2 0.0006
168 OSTEOPOROSIS 26 0.0006
169 CHRONIC KIDNEY DISEASE 48 0.0006
170 PROTEINURIA 12 0.0006
171 CUSHINGOID 2 0.0006
172 SHOULDER FRACTURE 1 0.0006
173 INFUSION SITE HAEMORRHAGE 2 0.0006
174 GLIOBLASTOMA 1 0.0006
175 FANCONI SYNDROME ACQUIRED 1 0.0006
176 BEHAVIOUR DISORDER 3 0.0006
177 EMOTIONAL DISTRESS 65 0.0005
178 LUPUS NEPHRITIS 1 0.0005
179 QUALITY OF LIFE DECREASED 7 0.0005
180 HEPATIC MASS 1 0.0005
181 METABOLIC DISORDER 3 0.0005
182 CONVERSION DISORDER 1 0.0005
183 VITAMIN D DEFICIENCY 5 0.0005
184 HYPERTRIGLYCERIDAEMIA 3 0.0005
185 DECREASED INTEREST 3 0.0005
186 TYPE 1 DIABETES MELLITUS 3 0.0005
187 INJECTION SITE NECROSIS 1 0.0005
188 ARTHRITIS BACTERIAL 2 0.0005
189 CHEST INJURY 1 0.0005
190 SKIN INDURATION 1 0.0005
191 LIVE BIRTH 4 0.0005
192 INFUSION SITE SWELLING 3 0.0005
193 MULTIPLE INJURIES 3 0.0005
194 DEVICE CONNECTION ISSUE 1 0.0005
195 OPTIC NEUROPATHY 1 0.0005
196 DECREASED ACTIVITY 5 0.0005
197 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
198 GASTRIC BYPASS 1 0.0005
199 BIPOLAR I DISORDER 1 0.0005
200 FEAR OF DEATH 1 0.0004
201 CHRONIC GASTRITIS 1 0.0004
202 BRAIN OPERATION 1 0.0004
203 CYTOMEGALOVIRUS COLITIS 1 0.0004
204 ENCEPHALITIS 3 0.0004
205 LARGE INTESTINE POLYP 3 0.0004
206 NEPHROPATHY 4 0.0004
207 MULTIPLE FRACTURES 7 0.0004
208 SARCOIDOSIS 2 0.0004
209 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
210 HUMERUS FRACTURE 2 0.0004
211 LYMPHADENITIS 1 0.0004
212 ACUTE PSYCHOSIS 1 0.0004
213 PROTEIN URINE PRESENT 2 0.0004
214 VENOOCCLUSIVE DISEASE 1 0.0004
215 HYPERPARATHYROIDISM SECONDARY 1 0.0004
216 EYELID PTOSIS 4 0.0004
217 LACTOSE INTOLERANCE 1 0.0004
218 FEMORAL NECK FRACTURE 2 0.0004
219 HEPATOSPLENOMEGALY 1 0.0004
220 AORTIC ARTERIOSCLEROSIS 1 0.0004
221 PHYSICAL DECONDITIONING 1 0.0004
222 BLOOD POTASSIUM ABNORMAL 1 0.0004
223 HYPERLACTACIDAEMIA 1 0.0004
224 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
225 RESPIRATORY SYMPTOM 1 0.0004
226 PARANOIA 6 0.0003
227 EXERCISE TOLERANCE DECREASED 2 0.0003
228 APATHY 5 0.0003
229 GLUCOSE TOLERANCE IMPAIRED 2 0.0003
230 HIV INFECTION 1 0.0003
231 THROMBOPHLEBITIS SUPERFICIAL 1 0.0003
232 IRITIS 1 0.0003
233 DYSAESTHESIA 1 0.0003
234 DUODENITIS 1 0.0003
235 LIVER INJURY 8 0.0003
236 PORTAL HYPERTENSION 1 0.0003
237 APPENDICITIS 3 0.0003
238 FOREIGN BODY IN THROAT 1 0.0003
239 BREAST CANCER RECURRENT 1 0.0003
240 PROCTALGIA 2 0.0003
241 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 8 0.0003
242 INFUSION SITE PAIN 4 0.0003
243 LIVER ABSCESS 1 0.0003
244 INJECTION SITE INFECTION 1 0.0003
245 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
246 UVEITIS 4 0.0003
247 WOUND COMPLICATION 1 0.0003
248 TACHYPHRENIA 1 0.0003
249 HYPERTRANSAMINASAEMIA 2 0.0003
250 RENAL IMPAIRMENT 24 0.0003
251 ERYTHEMA NODOSUM 1 0.0003
252 HAEMORRHAGIC DIATHESIS 1 0.0003
253 BIPOLAR DISORDER 3 0.0003
254 BONE LOSS 4 0.0003
255 CHEMOTHERAPY 1 0.0003
256 PRODUCT STORAGE ISSUE 1 0.0003
257 FOOT FRACTURE 5 0.0003
258 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
259 JAUNDICE 7 0.0003
260 NIGHTMARE 9 0.0003
261 ANKLE FRACTURE 4 0.0003
262 PROCEDURAL HAEMORRHAGE 1 0.0003
263 HALLUCINATION, AUDITORY 4 0.0003
264 ANXIETY 71 0.0002
265 MUSCLE HAEMORRHAGE 1 0.0002
266 INTRACRANIAL ANEURYSM 1 0.0002
267 RENAL FAILURE 33 0.0002
268 HEPATITIS C 3 0.0002
269 PERIPHERAL ISCHAEMIA 1 0.0002
270 HYPERURICAEMIA 1 0.0002
271 ESCHERICHIA INFECTION 2 0.0002
272 TOOTH LOSS 5 0.0002
273 NEPHROLITHIASIS 11 0.0002
274 PSYCHOTIC DISORDER 7 0.0002
275 PYELONEPHRITIS 2 0.0002
276 DYSPHEMIA 1 0.0002
277 SPINAL OSTEOARTHRITIS 2 0.0002
278 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
279 ABDOMINAL ABSCESS 1 0.0002
280 LOSS OF LIBIDO 2 0.0002
281 OROPHARYNGEAL DISCOMFORT 2 0.0002
282 HAEMOGLOBIN INCREASED 1 0.0002
283 LUMBAR VERTEBRAL FRACTURE 1 0.0002
284 ABNORMAL DREAMS 6 0.0002
285 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
286 CONJUNCTIVITIS 4 0.0002
287 EYE DISORDER 7 0.0002
288 SQUAMOUS CELL CARCINOMA 2 0.0002
289 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 10 0.0002
290 GASTROINTESTINAL TOXICITY 1 0.0002
291 TYPE 2 DIABETES MELLITUS 7 0.0002
292 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
293 RENAL TUBULAR NECROSIS 2 0.0002
294 THERAPY CHANGE 2 0.0002
295 HYPERVOLAEMIA 1 0.0002
296 RENAL INJURY 6 0.0002
297 BLOOD CREATININE INCREASED 13 0.0002
298 TOXIC EPIDERMAL NECROLYSIS 3 0.0002
299 PATHOLOGICAL FRACTURE 1 0.0002
300 ENDOCARDITIS 1 0.0002
301 PULMONARY HYPERTENSION 4 0.0002
302 MALABSORPTION 1 0.0002
303 INCONTINENCE 2 0.0002
304 PRODUCT RESIDUE PRESENT 1 0.0002
305 BACK INJURY 2 0.0002
306 STREPTOCOCCAL INFECTION 1 0.0002
307 NECROSIS 1 0.0002
308 PRODUCT LEAKAGE 1 0.0002
309 MICTURITION URGENCY 2 0.0002
310 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
311 MYOCARDITIS 2 0.0002
312 DYSSTASIA 5 0.0002
313 SEXUAL DYSFUNCTION 2 0.0002
314 ACUTE MYOCARDIAL INFARCTION 5 0.0002
315 ENERGY INCREASED 1 0.0002
316 BRADYKINESIA 1 0.0002
317 TREATMENT FAILURE 14 0.0002
318 OESOPHAGEAL CARCINOMA 5 0.0002
319 POLYNEUROPATHY 2 0.0002
320 HEPATITIS B 1 0.0002
321 INJECTION SITE VESICLES 1 0.0002
322 OSTEOARTHRITIS 7 0.0002
323 ADRENAL INSUFFICIENCY 2 0.0002
324 NOCTURIA 2 0.0002
325 SCHIZOPHRENIA 2 0.0002
326 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
327 CHOLANGITIS 1 0.0002
328 HEPATIC STEATOSIS 3 0.0002
329 MUSCLE ATROPHY 2 0.0002
330 LIVER DISORDER 7 0.0002
331 ERECTILE DYSFUNCTION 4 0.0002
332 NODULE 2 0.0002
333 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
334 ABNORMAL BEHAVIOUR 6 0.0002
335 DEPRESSED MOOD 8 0.0002
336 CORONAVIRUS INFECTION 1 0.0002
337 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
338 APPETITE DISORDER 1 0.0002
339 ACUTE KIDNEY INJURY 23 0.0002
340 POST-TRAUMATIC STRESS DISORDER 1 0.0001
341 WRONG PRODUCT ADMINISTERED 1 0.0001
342 DISEASE RECURRENCE 7 0.0001
343 RIB FRACTURE 3 0.0001
344 EXPOSURE DURING PREGNANCY 9 0.0001
345 DEMENTIA 4 0.0001
346 HALLUCINATION, VISUAL 3 0.0001
347 PAPULE 1 0.0001
348 SLEEP DISORDER 10 0.0001
349 PRODUCT SUPPLY ISSUE 1 0.0001
350 METASTASIS 1 0.0001
351 IRRITABLE BOWEL SYNDROME 3 0.0001
352 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
353 DRUG INTERACTION 22 0.0001
354 PRODUCT PRESCRIBING ISSUE 3 0.0001
355 FEELING DRUNK 1 0.0001
356 HEPATIC FAILURE 4 0.0001
357 HIP ARTHROPLASTY 2 0.0001
358 LIPASE INCREASED 1 0.0001
359 HAEMORRHAGIC STROKE 1 0.0001
360 DEPRESSION 29 0.0001
361 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
362 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
363 RENAL CYST 1 0.0001
364 PANCYTOPENIA 7 0.0001
365 FLATULENCE 7 0.0001
366 POST PROCEDURAL INFECTION 1 0.0001
367 OSTEONECROSIS 4 0.0001
368 MANIA 2 0.0001
369 DRUG LEVEL INCREASED 2 0.0001
370 POLLAKIURIA 5 0.0001
371 ADVERSE EVENT 11 0.0001
372 SENSATION OF FOREIGN BODY 1 0.0001
373 CANDIDA INFECTION 2 0.0001
374 HYPERTENSION 25 0.0001
375 DYSPHAGIA 11 0.0001
376 MYOPATHY 1 0.0001
377 PAIN 71 0.0001
378 DIPLOPIA 3 0.0001
379 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
380 DRUG INTOLERANCE 11 0.0001
381 PANCREATITIS 6 0.0001
382 IMMUNOSUPPRESSION 1 0.0001
383 GALLBLADDER DISORDER 2 0.0001
384 THIRST 2 0.0001
385 HAEMARTHROSIS 1 0.0001
386 FEAR 3 0.0001
387 SUICIDAL IDEATION 10 0.0001
388 PRODUCT DOSE OMISSION ISSUE 32 0.0001
389 FRACTURE 2 0.0001
390 SPINAL DISORDER 1 0.0001
391 GASTRIC ULCER 2 0.0001
392 CHOLESTASIS 2 0.0001
393 AFFECT LABILITY 1 0.0001
394 GLAUCOMA 2 0.0001
395 HOSPICE CARE 1 0.0001
396 INABILITY TO AFFORD MEDICATION 1 0.0001
397 UPPER LIMB FRACTURE 2 0.0001
398 AGGRESSION 5 0.0001
399 NO ADVERSE EVENT 18 0.0001
400 TOXIC SKIN ERUPTION 1 0.0001
401 PRODUCT PHYSICAL ISSUE 2 0.0001
402 CORONARY ARTERY DISEASE 3 0.0001
403 SUICIDE ATTEMPT 6 0.0001
404 HYPOTHERMIA 1 0.0001
405 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
406 DRUG LEVEL DECREASED 1 0.0001
407 TOOTH ABSCESS 1 0.0001
408 MOBILITY DECREASED 7 0.0001
409 SKELETAL INJURY 1 0.0001
410 PERITONITIS 2 0.0001
411 HYPERBILIRUBINAEMIA 1 0.0001
412 PETECHIAE 1 0.0001
413 WEIGHT FLUCTUATION 1 0.0001
414 TRANSFUSION 1 0.0001
415 AGITATION 7 0.0001
416 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
417 RENAL PAIN 1 0.0001
418 BODY HEIGHT DECREASED 1 0.0001
419 NIGHT SWEATS 3 0.0001
420 HALLUCINATION 7 0.0001
421 PRODUCT DOSE OMISSION 6 0.0001
422 DIABETES MELLITUS 7 0.0001
423 OESOPHAGITIS 1 0.0001
424 IMPAIRED HEALING 3 0.0001
425 ASPIRATION 1 0.0001
426 INJECTION SITE NODULE 1 0.0001
427 TOOTH FRACTURE 1 0.0001
428 TRANSAMINASES INCREASED 2 0.0001
429 RASH MACULO-PAPULAR 2 0.0001
430 MALNUTRITION 1 0.0001
431 WEIGHT INCREASED 20 0.0001
432 NEPHROPATHY TOXIC 1 0.0001
433 PANCREATITIS ACUTE 2 0.0001
434 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
435 STATUS EPILEPTICUS 1 0.0001
436 MYOCARDIAL ISCHAEMIA 1 0.0001
437 VASCULITIS 1 0.0001
438 BACTERAEMIA 1 0.0001
439 CHOLECYSTITIS 1 0.0001
440 WRIST FRACTURE 1 0.0001
441 TENDON RUPTURE 1 0.0001
442 PHARYNGITIS 1 0.0001
443 DYSPNOEA EXERTIONAL 3 0.0001
444 DERMATITIS ALLERGIC 1 0.0001
445 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
446 COLITIS 3 0.0001
447 ROTATOR CUFF SYNDROME 1 0.0001
448 ABDOMINAL DISTENSION 8 0.0001
449 IMMUNE SYSTEM DISORDER 1 0.0001
450 NEOPLASM MALIGNANT 5 0.0001
451 PRODUCT USE ISSUE 14 0.0001
452 ANAEMIA 14 0.0001
453 IMPAIRED GASTRIC EMPTYING 1 0.0001
454 HOSPITALISATION 11 0.0001
455 MASS 1 0.0001
456 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
457 PAIN IN JAW 2 0.0001
458 HEPATOCELLULAR INJURY 1 0.0001
459 DIALYSIS 1 0.0001
460 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
461 ANGINA PECTORIS 2 0.0001
462 HYPERTHYROIDISM 1 0.0001
463 LIVER FUNCTION TEST ABNORMAL 2 0.0001
464 FLUID OVERLOAD 1 0.0001
465 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
466 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
467 PULMONARY MASS 1 0.0001
468 INSURANCE ISSUE 1 0.0001
469 HYPOKALAEMIA 3 0.0001
470 EMOTIONAL DISORDER 2 0.0001
471 LYMPHOMA 1 0.0001
472 NERVOUS SYSTEM DISORDER 2 0.0001
473 BRAIN FOG 1 0.0001
474 DRUG-INDUCED LIVER INJURY 2 0.0001
475 ULCER 1 0.0001
476 HIP FRACTURE 2 0.0001
477 MUSCLE TIGHTNESS 1 0.0001
478 DEATH 53 0.0001
479 CYTOMEGALOVIRUS INFECTION 1 0.0001
480 VIRAL INFECTION 2 0.0001
481 GAIT INABILITY 2 0.0001
482 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
483 HEMIPARESIS 1 0.0001
484 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
485 MUSCULOSKELETAL DISCOMFORT 1 0.0001
486 DEVICE DEFECTIVE 1 0.0001
487 GAIT DISTURBANCE 11 0.0001
488 DEVICE USE ISSUE 1 0.0001
489 NEUROTOXICITY 1 0.0001
490 EOSINOPHILIA 1 0.0001
491 HYPERKALAEMIA 2 0.0001
492 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
493 DRUG ERUPTION 1 0.0001
494 INSOMNIA 15 0.0001
495 CONDITION AGGRAVATED 17 0.0001
496 GASTROINTESTINAL DISORDER 5 0.0001
497 GOUT 1 0.0001
498 MYELOSUPPRESSION 2 0.0001
499 TOOTHACHE 1 0.0001
500 OSTEOMYELITIS 1 0.0001
501 PELVIC PAIN 1 0.0001
502 HYPERGLYCAEMIA 2 0.0001
503 PANIC ATTACK 2 0.0001
504 EYE SWELLING 2 0.0001
505 BACTERIAL INFECTION 1 0.0001
506 HEPATIC CIRRHOSIS 1 0.0001
507 EYE PAIN 3 0.0001
508 PHOTOPHOBIA 1 0.0001
509 DYSARTHRIA 2 0.0001
510 CEREBROVASCULAR ACCIDENT 9 0.0001
511 MYALGIA 9 0.0001
512 NAUSEA 41 0.0001
513 ERUCTATION 1 0.0001
514 PRESCRIBED OVERDOSE 1 0.0001
515 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
516 HAEMORRHOIDS 1 0.0001
517 ORAL HERPES 1 0.0001
518 DISABILITY 1 0.0001
519 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
520 DISORIENTATION 2 0.0001
521 CARDIAC FAILURE 4 0.0000
522 PRODUCT ADMINISTRATION ERROR 1 0.0000
523 ILL-DEFINED DISORDER 3 0.0000
524 FEEDING DISORDER 1 0.0000
525 DYSKINESIA 2 0.0000
526 BODY TEMPERATURE INCREASED 1 0.0000
527 CARDIAC ARREST 4 0.0000
528 JOINT INJURY 1 0.0000
529 IMPAIRED WORK ABILITY 1 0.0000
530 WEIGHT DECREASED 13 0.0000
531 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
532 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
533 HEPATOTOXICITY 1 0.0000
534 HEPATIC ENZYME INCREASED 3 0.0000
535 MUSCULAR WEAKNESS 5 0.0000
536 PRODUCT AVAILABILITY ISSUE 1 0.0000
537 SKIN DISCOLOURATION 2 0.0000
538 SHOCK 1 0.0000
539 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
540 COGNITIVE DISORDER 2 0.0000
541 TREMOR 7 0.0000
542 COMA 2 0.0000
543 PRODUCT PRESCRIBING ERROR 1 0.0000
544 HEPATIC CANCER 1 0.0000
545 LOCALISED INFECTION 1 0.0000
546 INTERSTITIAL LUNG DISEASE 2 0.0000
547 RASH 18 0.0000
548 MENTAL IMPAIRMENT 1 0.0000
549 ENCEPHALOPATHY 1 0.0000
550 ASTHENIA 15 0.0000
551 ABDOMINAL PAIN LOWER 1 0.0000
552 GASTRIC CANCER 1 0.0000
553 HAEMATEMESIS 1 0.0000
554 THERAPY CESSATION 2 0.0000
555 OFF LABEL USE 34 0.0000
556 INFLAMMATION 2 0.0000
557 HAEMATOMA 1 0.0000
558 RESPIRATORY TRACT INFECTION 1 0.0000
559 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 2 0.0000
560 MUCOSAL INFLAMMATION 1 0.0000
561 GASTRITIS 1 0.0000
562 EAR INFECTION 1 0.0000
563 DIARRHOEA 24 0.0000
564 CONFUSIONAL STATE 6 0.0000
565 FREQUENT BOWEL MOVEMENTS 1 0.0000
566 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
567 LIMB INJURY 1 0.0000
568 DRUG ABUSE 3 0.0000
569 COMPLETED SUICIDE 3 0.0000
570 FATIGUE 28 0.0000
571 SEPSIS 4 0.0000
572 THROMBOCYTOPENIA 4 0.0000
573 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
574 INTENTIONAL DOSE OMISSION 1 0.0000
575 HYPERSOMNIA 1 0.0000
576 LETHARGY 2 0.0000
577 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
578 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
579 DECREASED APPETITE 8 0.0000
580 BONE PAIN 2 0.0000
581 ASCITES 1 0.0000
582 LABORATORY TEST ABNORMAL 1 0.0000
583 CATARACT 2 0.0000
584 APHASIA 1 0.0000
585 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
586 FEMUR FRACTURE 1 0.0000
587 CONSTIPATION 7 0.0000
588 MOOD SWINGS 1 0.0000
589 METABOLIC ACIDOSIS 1 0.0000
590 MOVEMENT DISORDER 1 0.0000
591 PNEUMONIA 10 0.0000
592 SWELLING FACE 2 0.0000
593 STAPHYLOCOCCAL INFECTION 1 0.0000
594 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
595 BLOOD PRESSURE DECREASED 2 0.0000
596 ABDOMINAL PAIN 7 0.0000
597 LIP SWELLING 1 0.0000
598 HAEMATURIA 1 0.0000
599 ILLNESS 3 0.0000
600 MEMORY IMPAIRMENT 4 0.0000
601 DRUG INEFFECTIVE 38 0.0000
602 DELIRIUM 1 0.0000
603 RASH MACULAR 1 0.0000
604 HEART RATE DECREASED 1 0.0000
605 HYPOXIA 1 0.0000
606 LYMPHADENOPATHY 1 0.0000
607 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
608 RESTLESSNESS 1 0.0000
609 HEADACHE 17 0.0000
610 INJECTION SITE MASS 1 0.0000
611 FALL 9 0.0000
612 INFLUENZA 3 0.0000
613 HEPATIC FUNCTION ABNORMAL 1 0.0000
614 HYPOAESTHESIA 4 0.0000
615 INCORRECT DOSE ADMINISTERED 6 0.0000
616 INJECTION SITE SWELLING 2 0.0000
617 DIZZINESS 13 0.0000
618 SEIZURE 3 0.0000
619 BACK PAIN 6 0.0000
620 FEELING ABNORMAL 6 0.0000
621 DRY MOUTH 2 0.0000
622 ABDOMINAL PAIN UPPER 5 0.0000
623 VISUAL IMPAIRMENT 3 0.0000
624 ROAD TRAFFIC ACCIDENT 1 0.0000
625 PRURITUS 9 0.0000
626 RECTAL HAEMORRHAGE 1 0.0000
627 DEVICE LEAKAGE 1 0.0000
628 PRODUCT STORAGE ERROR 2 0.0000
629 ANGIOEDEMA 1 0.0000
630 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
631 THERAPY NON-RESPONDER 1 0.0000
632 TINNITUS 1 0.0000
633 CHEST PAIN 4 0.0000
634 BLOOD CHOLESTEROL INCREASED 1 0.0000
635 ARRHYTHMIA 1 0.0000
636 NEUROPATHY PERIPHERAL 2 0.0000
637 MIGRAINE 2 0.0000
638 RASH ERYTHEMATOUS 1 0.0000
639 CONTUSION 2 0.0000
640 DYSPEPSIA 2 0.0000
641 PYREXIA 7 0.0000
642 CELLULITIS 1 0.0000
643 ERYTHEMA 4 0.0000
644 ARTHRALGIA 8 0.0000
645 HAEMORRHAGE 2 0.0000
646 ECZEMA 1 0.0000
647 PARAESTHESIA 3 0.0000
648 DISTURBANCE IN ATTENTION 1 0.0000
649 RASH PRURITIC 1 0.0000
650 DEPENDENCE 1 0.0000
651 HAEMATOCHEZIA 1 0.0000
652 URTICARIA 3 0.0000
653 TOXICITY TO VARIOUS AGENTS 3 0.0000
654 RHEUMATOID ARTHRITIS 2 0.0000
655 MYOCARDIAL INFARCTION 3 0.0000
656 PALPITATIONS 2 0.0000
657 SURGERY 1 0.0000
658 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 3 0.0000
659 IRRITABILITY 1 0.0000
660 THERAPEUTIC RESPONSE DECREASED 1 0.0000
661 STOMATITIS 1 0.0000
662 PLEURAL EFFUSION 1 0.0000
663 OEDEMA PERIPHERAL 2 0.0000
664 VERTIGO 1 0.0000
665 FEELING HOT 1 0.0000
666 HYPERSENSITIVITY 3 0.0000
667 PRODUCT USE IN UNAPPROVED INDICATION 4 0.0000
668 INJECTION SITE ERYTHEMA 2 0.0000
669 INTENTIONAL OVERDOSE 1 0.0000
670 DEEP VEIN THROMBOSIS 1 0.0000
671 ALOPECIA 3 0.0000
672 SOMNOLENCE 3 0.0000
673 VOMITING 7 0.0000
674 VISION BLURRED 2 0.0000
675 INJURY 1 0.0000
676 DYSPNOEA 8 0.0000
677 THERAPY INTERRUPTED 1 0.0000
678 PAIN IN EXTREMITY 4 0.0000
679 DYSGEUSIA 1 0.0000
680 HOT FLUSH 1 0.0000
681 ACNE 1 0.0000
682 BLOOD PRESSURE INCREASED 2 0.0000
683 PERIPHERAL SWELLING 2 0.0000
684 PROSTATE CANCER 1 0.0000
685 THROMBOSIS 1 0.0000
686 INFLUENZA LIKE ILLNESS 1 0.0000
687 SKIN EXFOLIATION 1 0.0000
688 URINARY TRACT INFECTION 2 0.0000
689 MUSCULOSKELETAL STIFFNESS 1 0.0000
690 COVID-19 2 0.0000
691 DRUG WITHDRAWAL SYNDROME 1 0.0000
692 TACHYCARDIA 1 0.0000
693 ADVERSE DRUG REACTION 1 0.0000
694 MUSCLE SPASMS 2 0.0000
695 CARDIAC DISORDER 1 0.0000
696 PULMONARY EMBOLISM 1 0.0000
697 ATRIAL FIBRILLATION 1 0.0000
698 SYNCOPE 1 0.0000
699 FLUSHING 1 0.0000
700 CHEST DISCOMFORT 1 0.0000
701 PLATELET COUNT DECREASED 1 0.0000
702 OVERDOSE 2 0.0000
703 MALAISE 4 0.0000
704 ASTHMA 1 0.0000
705 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
706 HYPERHIDROSIS 1 0.0000
707 DRY SKIN 1 0.0000
708 COUGH 2 0.0000
709 INFECTION 1 0.0000
710 INJECTION SITE PAIN 2 0.0000
711 DRUG DEPENDENCE 1 0.0000
712 BLOOD GLUCOSE INCREASED 1 0.0000